Oxford BioMedica plc Share Price London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 | 89.54M 113M 8.95B | Sales 2024 * | 129M 164M 12.95B | Capitalization | 320M 406M 32B |
---|---|---|---|---|---|
Net income 2023 | -157M -199M -15.7B | Net income 2024 * | -36M -45.62M -3.6B | EV / Sales 2023 | 2.38 x |
Net cash position 2023 * | 49.23M 62.38M 4.92B | Net cash position 2024 * | 15.86M 20.1M 1.59B | EV / Sales 2024 * | 2.35 x |
P/E ratio 2023 |
-1.35
x | P/E ratio 2024 * |
-8.95
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 26/03/23 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 28/08/17 |
Chairman | 68 | 23/06/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 30/04/23 |
Chairman | 68 | 23/06/20 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 31/05/16 |
1st Jan change | Capi. | |
---|---|---|
+7.60% | 111B | |
+11.36% | 106B | |
-12.46% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.02% | 16.81B | |
+38.23% | 12.54B | |
-24.40% | 8.09B |